{"date":"2025-08-01","count":44,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7762-2025-08-01-2004-1ta7vaa","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"20:04:57","subject":"公告本公司新任技術長","clause":"第11款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-08-01 20:04，「公告本公司新任技術長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-08-01-1925-srrxz3","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"19:25:31","subject":"公告本公司董事會決議委任第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-08-01 19:25，「公告本公司董事會決議委任第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-08-01-1911-xyhazt","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"19:11:28","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-08-01 19:11，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-08-01-1832-87qz4w","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"18:32:39","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-08-01 18:32，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-01-1829-hplbt1","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"18:29:15","subject":"補充公告本公司114年第一次股東臨時會相關事宜(增列討論事項及其他議案)","clause":"第17款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-01 18:29，「補充公告本公司114年第一次股東臨時會相關事宜(增列討論事項及其他議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-08-01-1806-4akw5l","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"18:06:03","subject":"公告本公司2025年第2季合併財務報告董事會預計召開日期為2025年8月11日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-08-01 18:06，「公告本公司2025年第2季合併財務報告董事會預計召開日期為2025年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-08-01-1801-4akw5l","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"18:01:31","subject":"公告本公司2025年第2季合併財務報告董事會預計召開日期為2025年8月11日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-08-01 18:01，「公告本公司2025年第2季合併財務報告董事會預計召開日期為2025年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-08-01-1749-12whb5i","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"17:49:26","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年08月11日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-08-01 17:49，「公告本公司114年第二季財務報告董事會預計召開日期為114年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-08-01-1740-1surenn","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"17:40:14","subject":"公告本公司114年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-08-01 17:40，「公告本公司114年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-08-01-1708-1xj0bi7","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"17:08:23","subject":"更正子公司資金貸與資訊揭露明細表","clause":"第53款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-08-01 17:08，「更正子公司資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2025-08-01-1704-1ywmgay","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"17:04:42","subject":"公告本公司發言人異動案","clause":"第11款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2025-08-01 17:04，「公告本公司發言人異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2025-08-01-1704-aa2zln","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"17:04:13","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第43款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2025-08-01 17:04，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2025-08-01-1700-68yr6f","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"17:00:19","subject":"本公司受邀參加福邦證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2025-08-01 17:00，「本公司受邀參加福邦證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-08-01-1647-p2vyxw","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"16:47:41","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年8月11日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-08-01 16:47，「公告本公司114年第二季財務報告董事會預計召開日期為114年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-08-01-1612-1fopu0r","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"16:12:11","subject":"公告本公司董事會決議114年第2季股利發放","clause":"第14款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-08-01 16:12，「公告本公司董事會決議114年第2季股利發放」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-08-01-1610-17doker","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"16:10:19","subject":"公告本公司董事會通過民國114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-08-01 16:10，「公告本公司董事會通過民國114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-08-01-1609-g8j19f","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"16:09:06","subject":"本公司114年第二季財務報告董事會預計召開日期為114年08月12日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-08-01 16:09，「本公司114年第二季財務報告董事會預計召開日期為114年08月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2025-08-01-1607-muluxb","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"16:07:36","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2025-08-01 16:07，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-08-01-1605-nhbes6","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"16:05:50","subject":"公告本公司董事會通過114年第二季個別財務報告","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-08-01 16:05，「公告本公司董事會通過114年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-08-01-1603-kxgk3x","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"16:03:40","subject":"公告本公司發言人及代理發言人異動","clause":"第8款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-08-01 16:03，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-01-1603-z4bg6k","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"16:03:35","subject":"公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價格相關事宜","clause":"第44款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-01 16:03，「公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價格相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-08-01-1603-17up2wc","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"16:03:20","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"第11款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-08-01 16:03，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-01-1603-1bnswtb","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"16:03:03","subject":"公告本公司初次上櫃現金增資委託代收及存儲價款機構","clause":"第44款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-01 16:03，「公告本公司初次上櫃現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-01-1559-qkrt5g","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"15:59:28","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"第44款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-01 15:59，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-01-1559-1kfrbrs","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"15:59:09","subject":"(補充7/30及7/31公告)本公司董事會決議以資本公積彌補虧損","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-01 15:59，「(補充7/30及7/31公告)本公司董事會決議以資本公積彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-08-01-1546-drgvb6","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"15:46:25","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-08-01 15:46，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-08-01-1545-1ddrlsd","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-08-01","time":"15:45:44","subject":"公告本公司董事會通過114年上半年度財務報告","clause":"第43款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-08-01 15:45，「公告本公司董事會通過114年上半年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-08-01-1539-26uk87","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"15:39:18","subject":"公告本公司向關係人租賃取得不動產使用權資產(補充公告交易相對人異動)(經董事會決議通過)","clause":"第20款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-08-01 15:39，「公告本公司向關係人租賃取得不動產使用權資產(補充公告交易相對人異動)(經董事會決議通過)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-08-01-1533-1jhewlf","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"15:33:19","subject":"公告本公司公司治理主管異動","clause":"第8款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-08-01 15:33，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-08-01-1510-hny49","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"15:10:30","subject":"公告本公司上傳2025年現金增資發行新股公開說明書(價格確定版更新律師法律意見書)","clause":"第51款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-08-01 15:10，「公告本公司上傳2025年現金增資發行新股公開說明書(價格確定版更新律師法律意見書)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-08-01-1451-sqarw3","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"14:51:37","subject":"公告本公司民國114年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-08-01 14:51，「公告本公司民國114年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-08-01-1451-1b3jhy1","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"14:51:34","subject":"公告本公司114年第二季財務報告預計提報董事會召開日期為114年08月11日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-08-01 14:51，「公告本公司114年第二季財務報告預計提報董事會召開日期為114年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-08-01-1441-1v8csyl","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"14:41:03","subject":"公告本公司114年第二季合併財務報告董事會預計召開日期為114年08月11日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-08-01 14:41，「公告本公司114年第二季合併財務報告董事會預計召開日期為114年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-01-1435-1jy9bws","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"14:35:26","subject":"(補充7/31公告)黃坤鍵董事於7月31日辭職,同任期董事變動已達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-01 14:35，「(補充7/31公告)黃坤鍵董事於7月31日辭職,同任期董事變動已達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2025-08-01-1412-n2a3y9","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"14:12:30","subject":"公告本公司受台新證券邀請，舉辦實體法說會","clause":"第12款","fact_date":"2025-09-02","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2025-08-01 14:12，「公告本公司受台新證券邀請，舉辦實體法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-08-01-1406-n2a3y9","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"14:06:52","subject":"公告本公司受台新證券邀請，舉辦實體法說會","clause":"第12款","fact_date":"2025-09-02","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-08-01 14:06，「公告本公司受台新證券邀請，舉辦實體法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-08-01-1405-n2a3y9","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"14:05:54","subject":"公告本公司受台新證券邀請，舉辦實體法說會","clause":"第12款","fact_date":"2025-09-02","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-08-01 14:05，「公告本公司受台新證券邀請，舉辦實體法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-08-01-1403-15elaqu","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"14:03:36","subject":"本公司受邀參加摩根士丹利舉辦之英文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-08-01 14:03，「本公司受邀參加摩根士丹利舉辦之英文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-08-01-1402-c2h6ra","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"14:02:51","subject":"本公司受邀參加元大證券舉辦之中文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-08-01 14:02，「本公司受邀參加元大證券舉辦之中文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-08-01-1400-1ian8nx","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"14:00:44","subject":"公告本公司114年第二季合併財務報告董事會召開日期為114年08月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-08-01 14:00，「公告本公司114年第二季合併財務報告董事會召開日期為114年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-08-01-1350-1cdq0nw","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"13:50:06","subject":"公告本公司114年第二季合併財務報告提報董事會","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-08-01 13:50，「公告本公司114年第二季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-08-01-1334-87qz4w","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"13:34:07","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-08-01 13:34，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-08-01-1128-1ycumvv","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-08-01","time":"11:28:23","subject":"公告本公司114年第二季合併財務報告董事會預計召開日期為114年8月13日","clause":"第31款","fact_date":"2025-08-01","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-08-01 11:28，「公告本公司114年第二季合併財務報告董事會預計召開日期為114年8月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-08-01-0151-1w480ds","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-08-01","time":"01:51:40","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年08月08日","clause":"第31款","fact_date":"2025-07-31","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-08-01 01:51，「公告本公司114年第二季財務報告董事會預計召開日期為114年08月08日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}